Bios I Pharma ApS: Financial statements 2015
CVR: 32672620
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
Bios I Pharma ApS (CVR 32672620) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -7,025 and a net result of DKK -2,341 compared with DKK -2,385 the year before. Equity in the 2015 report amounted to DKK 113,273. The solvency ratio was 89.8%.
- Gross Profit
- DKK -7,025
- Profit/Loss
- DKK -2,341
- Equity
- DKK 113,273
- Total Assets
- DKK 126,148
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -7K | -2K | 113K | - |
| 2014 | - | -7K | -2K | 116K | - |
| 2013 | - | -7K | -4K | 118K | - |
Official annual report
How creditworthy is Bios I Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Bios I Pharma ApS
Bios I Pharma ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AC 01 ApS. The management consists of Henrik Beier Jessen. The company is owned by Beier Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,061 and a net result of DKK 206,285 compared with DKK 1,732,448 the year before. Equity in the 2025 report amounted to DKK 445,202.